HLTH 2026 Preview: Jason Carney on Closing Care Gaps

Clinical Strategy

Women’s health is finally getting the investment and attention it deserves, and HLTH 2026 is where that momentum comes together with AI and the business of care. I’m excited to be in Las Vegas, November 15–18, to connect with the leaders turning that attention into better outcomes.

What I’m Looking Forward to at HLTH 2026

1. Closing care gaps that start in the lab. I’m looking forward to connecting with leaders focused on addressing gaps in women’s health that too often go undetected. Earlier identification of conditions like anemia can make a meaningful difference in patient outcomes. I’m excited to explore how we can continue advancing Clinical IQ™ to make early detection and intervention a routine part of care.
2. Where clinical quality and financial performance meet. When a lab result leads to the right action at the right time, we can reduce unnecessary testing, avoid downstream costs, and improve patient outcomes. Those are the conversations I want to be part of, especially as we look to expand Clinical IQ™ into the payer market, connecting health plans and providers to identify care gaps, improve quality, and drive better outcomes across patient populations.
3. Seeing AI move from the keynote to the bedside. I’m most looking forward to seeing how healthcare organizations are moving beyond the conversation around AI and putting it into clinical practice. That’s exactly what we’re building with Clinical IQ, turning lab data into actionable intelligence that helps clinicians make better decisions and improve patient care.

Lab data is the earliest signal in healthcare, and it’s time health plans put it to work.

About Clinical IQ™

hc1 Clinical IQ™ turns lab results and clinical data into action, using clinician-built AI to help care teams close gaps across anemia management, patient blood management, women’s health, and lab stewardship. It works inside the EHR, so insights appear where teams already work.